Loading patent…
AssigneesShenzhen Research Institute of the Hong Kong Polytechnic University, Fudan University
InventorsYanxiang ZHAO, Xianxiu QIU, Xiaozhe ZHANG, Na LI, Renxiao WANG
Estimating the term…
A Beclin 1-targeting stapled peptide and a pharmaceutical composition. The stapled peptide includes an amino acid sequence at least 66.7% identical to amino acid residues 191-205 of Beclin 1, an amino acid residue E195 and an amino acid residue N202 in the stapled peptide are connected by a hydrocarbon staple to stabilize the α-helical structure of the stapled peptide. The hydrocarbon staple is located at a position in the stapled peptide closer to the Beclin1 coiled coil domain-stapled peptide binding interface, which can enhance the binding affinity of the stapled peptide to Beclin 1 by 10-30 fold. Compared to other autophagy inducers like rapamycin and Tat-Beclin 1 peptide, the optimized stapled peptide shows the unique profile of not only inducing autophagy but also significantly enhancing the endolysosomal degradation of cell surface oncogenic receptors EGFR and HER2 in HER2-positive cancer cells.
A Beclin 1-targeting stapled peptide, wherein the stapled peptide comprises an amino acid sequence at least 66.7% identical to amino acid residues 191-205 of Beclin 1, a fifth amino acid residue and a twelfth amino acid residue in the stapled peptide are connected by a hydrocarbon staple to stabilize an α-helical structure of the stapled peptide, the amino acid sequence of the stapled peptide is SEQ ID NO. 21 and SEQ ID NO. 32.
(canceled)
A pharmaceutical composition, wherein comprising the stapled peptide comprising an amino acid sequence at least 66.7% identical to amino acid residues 191-205 of Beclin 1, a fifth amino acid residue and a twelfth amino acid residue in the stapled peptide are connected by a hydrocarbon staple to stabilize an α-helical structure of the stapled peptide, the amino acid sequence of the stapled peptide is SEQ ID NO. 21 and SEQ ID NO. 32.
Dependencies are inferred from the claim text.